DEL PRATO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 43.459
EU - Europa 16.544
AS - Asia 5.444
AF - Africa 280
SA - Sud America 47
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 24
Totale 65.828
Nazione #
US - Stati Uniti d'America 42.130
IT - Italia 5.775
CN - Cina 3.406
SE - Svezia 2.694
BG - Bulgaria 2.016
UA - Ucraina 1.377
DE - Germania 1.359
CA - Canada 1.301
GB - Regno Unito 802
FI - Finlandia 714
VN - Vietnam 700
CH - Svizzera 633
TR - Turchia 612
AT - Austria 325
HK - Hong Kong 283
RU - Federazione Russa 277
BE - Belgio 188
FR - Francia 188
SG - Singapore 170
CI - Costa d'Avorio 140
IN - India 104
SN - Senegal 78
IR - Iran 39
NG - Nigeria 39
PL - Polonia 36
NL - Olanda 34
IL - Israele 32
BR - Brasile 26
KR - Corea 25
IE - Irlanda 24
EU - Europa 23
AU - Australia 22
MX - Messico 22
ES - Italia 21
JP - Giappone 17
GR - Grecia 15
RO - Romania 13
EG - Egitto 9
DK - Danimarca 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
CZ - Repubblica Ceca 7
MY - Malesia 6
TW - Taiwan 6
BD - Bangladesh 5
CL - Cile 5
HR - Croazia 5
ID - Indonesia 5
NO - Norvegia 5
PK - Pakistan 5
CO - Colombia 4
EE - Estonia 4
MA - Marocco 4
QA - Qatar 4
SC - Seychelles 4
TH - Thailandia 4
AR - Argentina 3
HU - Ungheria 3
IQ - Iraq 3
KZ - Kazakistan 3
RS - Serbia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
EC - Ecuador 2
GT - Guatemala 2
IS - Islanda 2
JO - Giordania 2
LT - Lituania 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
VE - Venezuela 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
NE - Niger 1
NP - Nepal 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 65.828
Città #
Woodbridge 6.656
Ann Arbor 5.211
Fairfield 4.434
Houston 4.382
Chandler 2.852
Milan 2.510
Ashburn 2.232
Sofia 2.011
Jacksonville 1.995
Seattle 1.810
Wilmington 1.597
Cambridge 1.501
Ottawa 1.251
Beijing 1.160
New York 1.139
Princeton 917
Lawrence 782
Nanjing 712
Medford 673
Bern 628
Izmir 577
Serra 519
Des Moines 477
Jüchen 350
Dearborn 345
Nanchang 288
San Diego 287
Hong Kong 270
Vienna 258
Dong Ket 254
Boulder 252
Rome 193
Brussels 186
Redwood City 171
Kunming 165
Shenyang 141
Abidjan 140
Falls Church 137
Bremen 133
Florence 126
Changsha 122
Hebei 113
Pisa 110
Jiaxing 98
Tianjin 96
London 93
Ogden 92
Frankfurt am Main 89
Lancaster 86
Grafing 84
Hefei 79
Dakar 78
Washington 76
Norwalk 75
Boardman 58
Düsseldorf 57
Orange 57
Jinan 55
Hangzhou 54
Auburn Hills 44
Marseille 44
Guangzhou 43
Pune 42
Verona 40
Lagos 35
Chicago 34
Warsaw 33
Shanghai 29
Seacroft 28
San Francisco 27
Changchun 26
Detroit 26
Indiana 26
Lanzhou 26
Ningbo 26
Zhengzhou 26
Provo 25
Los Angeles 24
Nürnberg 23
Tappahannock 22
Phoenix 21
Chengdu 17
Costa Mesa 16
Kocaeli 16
Pasargad 16
Fuzhou 15
Simi Valley 14
Singapore 14
Toronto 14
Redmond 13
Dublin 12
Hanover 12
Mendicino 12
Vicopisano 12
Wuhan 12
Kilburn 10
Mexico City 10
São Paulo 10
Walnut 10
Xian 10
Totale 52.209
Nome #
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 289
Activation of the hexosamine pathway leads to phosphorylation of IRS-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mTOR insulin biosynthetic pathway in RIN pancreatic {beta}-cells 215
Gestational diabetes, inflammation, and late vascular disease 183
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 172
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 167
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 166
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes 164
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. 163
Absence of islet alpha cell function in pancreatectomized patients. 160
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 159
Prevalence and risk factors for gestational diabetes assessed by universal screening 158
Alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria JOURNAL OF HYPERTENSION JUN 2006 VL 24 IS 6 BP 1217 EP 1217 157
The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle. 154
Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients 154
A Common Polymorphism in the Promoter of UCP2 Contributes to the Variation in Insulin Secretion in Glucose-Tolerant Subjects 153
ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations. 152
A call to action - the UN Resolution on diabetes 151
The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats 150
Body composition study in the elderly: comparison between tritium dilution method and dual photon absorptiometry 150
Q192R PARAOXONASE(PON)1 POLYMORPHISM, INSULIN SENSITIVITY AND ENDOTHELIAL FUNCTION IN ESSENTIAL HYPERTENSIVE MEN 150
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 148
G-protein-coupled receptor 40 (GPR40) expression in human pancreatic 145
Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality. A study in Tuscany, Italy, over years 2004-2011 144
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism. 144
Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): A 3-yr metabolic and diabetic complications follow-up 144
Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes 143
An off-the-shelf instant contact casting device for the management of diabetic foot ulcers - A randomized prospective trial versus traditional fiberglass cast 143
G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids 143
null 142
Insulin resistance in Cushing's syndrome. 141
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy 141
What therapy do our NIDDM patients need? Insulin releasers 140
Functional and survival analysis of isolated human islets 140
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo 140
Selective screening for GDM in Italy: application and effectiveness of National Guidelines 139
Type 2 diabetes mellitus: focus on new treatments and special populations 139
Gliclazide protects isolated human islets from apoptosis induced by intermittent high glucose: the role of oxidative stress 138
We have the evidence, we need to act to improve diabetes care 138
Dipeptidyl peptidase 4 (DPP-4) inhibitors and their role in Type 2 diabetes management 138
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 137
ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension 137
Simultaneous pancreas-kidney transplantation is improved by living kidney donation program 136
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients 135
Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. 135
SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED, PILOT STUDY COMPARING CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 135
Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening. 134
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 133
Altered autophagy in the pancreatic beta cells of human type 2 diabetes 133
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. 132
ROLE OF G-PROTEIN-COUPLED RECEPTOR 40 (GPR40) IN NON-DIABETIC AND TYPE 2 DIABETIC PANCREATIC ISLETS. 132
Glucose transporter 2 gene polymorphisms and beta-cell function in isolated human pancreatic islets 132
Prognostic implications of diabetes phenotyping: new concepts for an old disease 132
The vascular effects of doxazosin in hypertension complicated by metabolic syndrome 132
The role of peripheral benzodiazepine receptors on the function and survival of isolated human pancreatic islets 132
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 132
Portal enteric-drained solitary pancreas transplantation without surveillance biopsy: is it safe? 132
Hyperglucagonemia and insulin-mediated glucose metabolism 131
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 131
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance 130
Long-Term (5 Years) Efficacy and Safety of Pancreas Transplantation Alone in Type 1 Diabetic Patients 130
Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII) 129
Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin 129
Effect of prolonged overnight fasting on energy metabolism in non-insulin-dependent diabetic and non-diabetic subjects 129
Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose 129
Successful solitary pancreas transplantation with portal-enteric drainage following unsuccessful islet cell transplantation 128
1-Hour OGTT Plasma Glucose as a Marker of Progressive Deterioration of Insulin Secretion and Action in Pregnant Women. 128
The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. 127
Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects. 127
A SINGLE CENTER, OPEN, PROSPECTIVE, RANDOMIZED COMPARISON OF CYCLOSPORINE VERSUS TACROLIMUS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION 127
Beta- and alpha-cell dysfunction in type 2 diabetes 127
Basal insulin and cardiovascular and other outcomes in dysglycemia. 127
Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin 127
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 126
Reconstructing the rate of appearance of subcutaneous insulin by deconvolution. 125
A telemedicine support for diabetes management: the T-IDDM project 125
Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus 125
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels 125
Oxidative stress in isolated human pancreatic islets: possible role of frataxin 125
Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. 125
Epigenetic regulation of PGC-1 alpha inhuman type 2 diabetic islets and effect on insulin secretion 124
Pancreas transplant alone (PTA) in type 1 diabetic patients (T1DM): a 3-year follow-up 124
Metabolic memory and individual treatment aims in type 2 diabetes--outcome-lessons learned from large clinical trials. 124
C-reactive protein and metabolic syndrome in women with previous gestational diabetes 124
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 124
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 123
Insulin Resistance and Lipid Disorders 123
An alternative and simple method to consistently prepare viable isolated human islets for clinical transplantation 123
The beneficial effects of pancreas transplant alone on diabetic nephropathy 122
PANCREAS TRANSPLANTATION: EFFECTS ON DIABETIC RETINOPATHY 122
Is there a local "incretin system" in human pancreatic islets? 122
Endothelial progenitor cells and endothelial dysfunction in prediabetic and newly diagnosed type 2 diabetic subjects 122
Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study. 122
The relationship between alanine and ketone body in vivo 121
Role of tissue specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle 121
Is maternal educational level a risk factor for gestational diabetes in Caucasian women? 121
Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets 121
Ninety-five percent insulin independence rate 3 years after pancreas transplantation alone with portal-enteric drainage 121
Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents 120
Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion 120
Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus 120
Totale 13.824
Categoria #
all - tutte 153.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.760


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.429 0 0 0 0 0 0 0 0 94 1.327 1.619 1.389
2019/202012.379 1.597 1.208 626 759 1.235 1.210 1.360 995 1.405 724 1.054 206
2020/20216.203 679 272 563 257 615 269 572 598 594 495 335 954
2021/20228.379 241 610 186 543 1.596 1.183 213 441 297 302 462 2.305
2022/20238.195 1.152 730 381 800 1.086 1.161 117 720 1.276 113 513 146
2023/20247.624 1.576 1.204 1.171 588 1.270 1.295 172 192 156 0 0 0
Totale 66.659